Literature DB >> 16687509

Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.

Grace E Stutzmann1, Ian Smith, Antonella Caccamo, Salvatore Oddo, Frank M Laferla, Ian Parker.   

Abstract

Neuronal Ca2+ signaling through inositol triphosphate receptors (IP3R) and ryanodine receptors (RyRs) must be tightly regulated to maintain cell viability, both acutely and over a lifetime. Exaggerated intracellular Ca2+ levels have been associated with expression of Alzheimer's disease (AD) mutations in young mice, but little is known of Ca2+ dysregulations during normal and pathological aging processes. Here, we used electrophysiological recordings with two-photon imaging to study Ca2+ signaling in nontransgenic (NonTg) and several AD mouse models (PS1KI, 3xTg-AD, and APPSweTauP301L) at young (6 week), adult (6 months), and old (18 months) ages. At all ages, the PS1KI and 3xTg-AD mice displayed exaggerated endoplasmic reticulum (ER) Ca2+ signals relative to NonTg mice. The PS1 mutation was the predominant "calciopathic" factor, because responses in 3xTg-AD mice were similar to PS1KI mice, and APPSweTauP301L mice were not different from controls. In addition, we uncovered powerful signaling interactions and differences between IP3R- and RyR-mediated Ca2+ components in NonTg and AD mice. In NonTg mice, RyR contributed modestly to IP3-evoked Ca2+, whereas the exaggerated signals in 3xTg-AD and PS1KI mice resulted primarily from enhanced RyR-Ca2+ release and were associated with increased RyR expression across all ages. Moreover, IP3-evoked membrane hyperpolarizations in AD mice were even greater than expected from exaggerated Ca2+ signals, suggesting increased coupling efficiency between cytosolic [Ca2+] and K+ channel regulation. We conclude that lifelong ER Ca2+ disruptions in AD are related to a modulation of RyR signaling associated with PS1 mutations and represent a discrete "calciumopathy," not merely an acceleration of normal aging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687509      PMCID: PMC6674246          DOI: 10.1523/JNEUROSCI.0739-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  166 in total

1.  Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation.

Authors:  Gary E Gibson; Huan-Lian Chen; Hui Xu; Linghua Qiu; Zuoshang Xu; Travis T Denton; Qingli Shi
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

2.  Reduction in neuronal L-type calcium channel activity in a double knock-in mouse model of Alzheimer's disease.

Authors:  Olivier Thibault; Tristano Pancani; Philip W Landfield; Christopher M Norris
Journal:  Biochim Biophys Acta       Date:  2012-01-10

Review 3.  Intracellular organelles in the saga of Ca2+ homeostasis: different molecules for different purposes?

Authors:  Enrico Zampese; Paola Pizzo
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

4.  Response to Shilling et al. (10.1074/jbc.M111.300491).

Authors:  Ilya Bezprozvanny; Charlene Supnet; Suya Sun; Hua Zhang; Bart De Strooper
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

5.  Role of presenilins in neuronal calcium homeostasis.

Authors:  Hua Zhang; Suya Sun; An Herreman; Bart De Strooper; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

Review 6.  Restoring calcium homeostasis to treat Alzheimer's disease: a future perspective.

Authors:  Elena Popugaeva; Olga L Vlasova; Ilya Bezprozvanny
Journal:  Neurodegener Dis Manag       Date:  2015-10-19

Review 7.  Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Authors:  Tae-In Kam; Youngdae Gwon; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2014-08-24       Impact factor: 9.261

8.  Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.

Authors:  Jason K Clark; Matthew Furgerson; Jonathon D Crystal; Marcus Fechheimer; Ruth Furukawa; John J Wagner
Journal:  Neurobiol Learn Mem       Date:  2015-09-15       Impact factor: 2.877

9.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

10.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.